Insider Selling: Arteris (NASDAQ:AIP) Major Shareholder Sells $653,500.00 in Stock

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 50,000 shares of the business’s stock in a transaction dated Wednesday, October 8th. The shares were sold at an average price of $13.07, for a total value of $653,500.00. Following the completion of the transaction, the insider owned 9,689,071 shares in the company, valued at $126,636,157.97. This trade represents a 0.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Monday, October 6th, Bayview Legacy, Llc sold 100,000 shares of Arteris stock. The stock was sold at an average price of $13.10, for a total value of $1,310,000.00.
• On Tuesday, August 5th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The stock was sold at an average price of $13.12, for a total value of $656,000.00.

Arteris Trading Down 5.5%

Shares of AIP stock opened at $12.39 on Monday. The company has a market cap of $528.43 million, a price-to-earnings ratio of -15.11 and a beta of 1.45. The stock has a 50 day simple moving average of $9.98 and a 200-day simple moving average of $8.61. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $14.58.

Arteris (NASDAQ:AIP) last issued its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.11). The business had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AIP has been the subject of a number of analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research note on Wednesday, October 8th. Wall Street Zen raised Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. Finally, TD Cowen upped their price target on Arteris from $12.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $15.00.

Institutional Investors Weigh In On Arteris

A number of large investors have recently bought and sold shares of AIP. Acadian Asset Management LLC grew its holdings in Arteris by 40.6% during the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company’s stock valued at $6,222,000 after buying an additional 260,277 shares during the last quarter. AQR Capital Management LLC acquired a new stake in Arteris during the 1st quarter valued at $1,621,000. Federated Hermes Inc. grew its holdings in Arteris by 97.2% during the 1st quarter. Federated Hermes Inc. now owns 327,119 shares of the company’s stock valued at $2,260,000 after buying an additional 161,241 shares during the last quarter. Franklin Resources Inc. grew its holdings in Arteris by 9.6% during the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company’s stock valued at $15,602,000 after buying an additional 142,936 shares during the last quarter. Finally, Next Century Growth Investors LLC grew its holdings in Arteris by 46.4% during the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company’s stock valued at $2,817,000 after buying an additional 129,143 shares during the last quarter. Institutional investors and hedge funds own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.